The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
Open accessAbstract
Cognate interactions between antigen-presenting B and T cells play crucial roles in immunologic responses. T cells that have been activated via the crosslinking of CD3 are able to induce B cell proliferation and immunoglobulin secretion in a major histocompatibility complex-unrestricted and contact-dependent manner. We find that such activated human CD4+ T cells, but not control Ig-treated T cells, may induce normal or leukemic B cells to express B7/BB1 and significantly higher levels of CD54 intercellular adhesion molecule 1 via a process that also requires direct cell-cell contact. To discern what cell surface molecule(s) may be responsible for signalling B cells to express B7/BB1, we added various monoclonal antibodies (mAbs) specific for T or B cell accessory molecules or control mAbs to cocultures of alpha-CD3-activated T cells and resting B cells. We find that only alpha-CD40 mAbs can significantly inhibit the increased expression of B7/BB1, suggesting that the ligand for CD40 expressed on activated T cells may be an important inducer of B7/BB1 expression. Subsequent experiments in fact demonstrate that alpha-CD40 mAbs, but not control mAbs, induce changes in B cell phenotype similar to those induced by activated T cells when the mAbs are presented on Fc gamma RII (CDw32)-expressing L cells. These phenotypic changes have significant effects on B cell function. Whereas chronic lymphocytic leukemia (CLL) B cells normally are very poor stimulators in allogeneic mixed lymphocyte reactions (MLRs), CLL-B cells preactivated via CD40 crosslinking are significantly better presenters of alloantigen, affecting up to 30-fold-greater stimulation of T cell proliferation than that induced by control treated or nontreated CLL-B cells. Similarly, the MLR of T cells stimulated by allogeneic nonleukemic B cells can be enhanced significantly if the stimulator B cells are preactivated via CD40 crosslinking. The enhanced MLR generated by such preactivated B cells may be inhibited by blocking B7/BB1-CD28 interaction with CTLA4Ig. These studies demonstrate a novel, CD40-dependent pathway for inducing B cell expression of B7/BB1 and enhancing B cell antigen-presenting cell activity that can be initiated via cell-cell contact with alpha-CD3-stimulated CD4+ T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Antigen-specific interaction between T and B cells
Lanzavecchia, A. (1985) · Nature · doi:10.1038/314537a0 · Cited by 1,412
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6550 · Cited by 804
Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A. (1992) · Science · doi:10.1126/science.1496399 · Cited by 790
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E., & Rousset, F. (1991) · Science · doi:10.1126/science.1702555 · Cited by 533
Cited by
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Elgueta, R., Benson, M. J., De Vries, V. C., Wasiuk, A., Guo, Y., & Noelle, R. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00782.x · Cited by 1,625
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
The B7 and CD28 receptor families
June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90080-9 · Cited by 1,296
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
B70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 909
Signals and signs for lymphocyte responses
Janeway, C. A., & Bottomly, K. (1994) · Cell · doi:10.1016/0092-8674(94)90335-2 · Cited by 848
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
CD40/CD154 Interactions at the Interface of Tolerance and Immunity
Quezada, S. A., Jarvinen, L. Z., Lind, E. F., & Noelle, R. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104533 · Cited by 683
How B and T cells talk to each other
Clark, E. A., & Ledbetter, J. A. (1994) · Nature · doi:10.1038/367425a0 · Cited by 641
IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E., & Noelle, R. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.591 · Cited by 626
Ramsay, A. G., Johnson, A. J., Lee, A. M., Gorgün, G., Le Dieu, R., Blum, W., Byrd, J. C., & Gribben, J. G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35017 · Cited by 600
The Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection
Sayegh, M. H., & Turka, L. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382506 · Cited by 577
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Burger, J. A., Ghia, P., Rosenwald, A., & Caligaris-Cappio, F. (2009) · Blood · doi:10.1182/blood-2009-06-225326 · Cited by 577
Sanz, I., Wei, C., Jenks, S. A., Cashman, K. S., Tipton, C., Woodruff, M. C., Hom, J., & Lee, F. E.-H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02458 · Cited by 569
Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., & Datta, S. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118643 · Cited by 517
Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., & Pober, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4342 · Cited by 472
Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand
Grewal, I. S., Xu, J., & Flavell, R. A. (1995) · Nature · doi:10.1038/378617a0 · Cited by 464
The Role of CD40 Ligand in Costimulation and T‐Cell Activation
Grewal, I. S., & Flavell, R. A. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00921.x · Cited by 449
Development and Selection of T Cells: Facts and Puzzles
Kisielow, P., & Von Boehmer, H. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60620-3 · Cited by 444
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Burger, J. A., & Wiestner, A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.121 · Cited by 431
Hancock, W. W., Sayegh, M. H., Zheng, X.-G., Peach, R., Linsley, P. S., & Turka, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13967 · Cited by 411
Parker, D. C., Greiner, D. L., Phillips, N. E., Appel, M. C., Steele, A. W., Durie, F. H., Noelle, R. J., Mordes, J. P., & Rossini, A. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9560 · Cited by 411
CD40 ligand-transduced co-stimulation of T cells in the development of helper function
Essen, D. V., Kikutani, H., & Gray, D. (1995) · Nature · doi:10.1038/378620a0 · Cited by 409
The role of CD40 in the regulation of humoral and cell-mediated immunity
Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., & Noelle, R. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90269-0 · Cited by 373
Brown, R. D., Pope, B., Murray, A., Esdale, W., Sze, D. M., Gibson, J., Ho, P. J., Hart, D., & Joshua, D. (2001) · Blood · doi:10.1182/blood.v98.10.2992 · Cited by 347
Caux, C., Vanbervliet, B., Massacrier, C., Azuma, M., Okumura, K., Lanier, L. L., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1841 · Cited by 346
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
Wierda, W. G., Cantwell, M. J., Woods, S. J., Rassenti, L. Z., Prussak, C. E., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.9.2917 · Cited by 340
Self-citationTargeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.005 · Cited by 334
Larsen, C. P., Alexander, D. Z., Hollenbaugh, D., Elwood, E. T., Ritchie, S. C., Aruffo, A., Hendrix, R., & Pearson, T. C. (1996) · Transplantation · doi:10.1097/00007890-199601150-00002 · Cited by 323
B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather
Caligaris-Cappio, F., & Hamblin, T. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.399 · Cited by 321
A central role of CD40 ligand in the regulation of CD4+ T-cell responses
Grewal, I. S., & Flavell, R. A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10030-x · Cited by 318
CD28-B7 interactions in T-cell activation
Allison, J. P. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90120-1 · Cited by 313
Fukuda, T., Chen, L., Endo, T., Tang, L., Lu, D., Castro, J. E., Widhopf, G. F., Rassenti, L. Z., Cantwell, M. J., Prussak, C. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712148105 · Cited by 312
Self-citationCD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
Van Kooten, C., & Banchereau, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60865-2 · Cited by 311
B cells as antigen presenting cells
Rodríguez-Pinto, D. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2006.02.005 · Cited by 297
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.
Ho, W. Y., Cooke, M. P., Goodnow, C. C., & Davis, M. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1539 · Cited by 292
Is cancer dangerous to the immune system?
Fuchs, E. J., & Matzinger, P. (1996) · Seminars in Immunology · doi:10.1006/smim.1996.0035 · Cited by 289
Burger, J. A., & Gribben, J. G. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.011 · Cited by 285
Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells
Furman, R. R., Asgary, Z., Mascarenhas, J. O., Liou, H.-C., & Schattner, E. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2200 · Cited by 278
Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D., & Chess, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1857 · Cited by 273
Expression and functional significance of an additional ligand for CTLA-4.
Lenschow, D. J., Su, G. H., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J., & Bluestone, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11054 · Cited by 259
The Roles of CD28 and CD40 Ligand in T Cell Activation and Tolerance
Howland, K. C., Ausubel, L. J., London, C. A., & Abbas, A. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4465 · Cited by 173
Molecular and cellular mechanisms of CLL: novel therapeutic approaches.
Pleyer, L., Egle, A., Hartmann, T. N., & Greil, R. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.72 · Cited by 125
Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells
Brouwer, R. E., Zwinderman, K. H., Kluin-Nelemans, H. C., van Luxemburg-Heijs, S. A. P., Willemze, R., & Falkenburg, J. H. F. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(99)00143-5 · Cited by 46
Metadata
- Authors
- Ranheim, E. A., & Kipps, T. J.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-04-01
- Volume
- 177
- Issue
- 4
- Pages
- 925-935
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1971487921
- Cited by
- 580
- References
- 48
- FWCI
- 16.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.